The 4 Stages of Wound Healing: A Clinical Overview

Wound healing is one of the most complex and precisely orchestrated processes in human biology. From the moment tissue is disrupted, the body initiates a cascade of cellular and biochemical events designed to restore integrity and function. Understanding how that process unfolds — and what it needs at each stage — is foundational to effective wound management.

Yet in clinical practice, product selection is often driven by habit, formulary defaults, or a one-size-fits-all approach. The result is dressings applied to wounds they are not optimized for, healing that stalls unnecessarily, and outcomes that fall short of what the patient deserves.

This guide breaks down the four stages of wound healing, what is happening biologically at each phase, and which products from the Nu Endeavors portfolio are best suited to support the wound at that moment.

The Four Stages at a Glance

Stage 1: Hemostasis — Stop the Bleeding, Protect the Site

What Is Happening

Within seconds of injury, vasoconstriction reduces blood flow to the wound. Platelets adhere to exposed collagen and release chemical signals that recruit more platelets, forming a platelet plug. The coagulation cascade converts fibrinogen to fibrin, reinforcing the clot and creating a scaffold for the cellular events that follow.

This phase is brief but critical. The fibrin matrix laid down during hemostasis serves as the structural foundation for the entire healing process. Disrupting it prematurely — through aggressive debridement or inappropriate dressing changes — can set healing back significantly.

Product Considerations

The primary goal at this stage is protection and stabilization. The wound needs to be covered to prevent contamination and maintain the clot without disruption.

• A non-adherent primary dressing that will not disturb the clot on removal
• A silicone secondary dressing to secure the primary layer without trauma to the wound edges
• Avoid highly absorbent dressings that may desiccate the clot or adhere to the wound bed

Stage 2: Inflammation — Control Infection, Support the Immune Response

What Is Happening

Inflammation is not a complication — it is a necessary and protective phase. Neutrophils arrive first, phagocytosing bacteria and cellular debris. Macrophages follow, continuing the cleanup and releasing growth factors that signal the transition to proliferation. Without adequate inflammation, wounds cannot progress.

The clinical challenge is distinguishing normal, productive inflammation from pathological inflammation driven by infection, critical colonization, or biofilm. A wound stuck in the inflammatory phase — characterized by persistent exudate, erythema, and failure to progress — requires active intervention.

Product Considerations

This is the phase where antimicrobial management becomes most critical. The goal is to reduce bacterial burden without damaging the host tissue or impairing the immune response.

PHMB Antimicrobial Wound Gel

PHMB (polyhexamethylene biguanide) antimicrobial wound gel is designed for wounds with elevated bacterial burden or signs of critical colonization. PHMB is a broad-spectrum antimicrobial agent with a well-documented safety profile — it is effective against gram-positive and gram-negative bacteria, fungi, and biofilm, and has demonstrated favorable cytotoxicity profiles in published research compared to some alternative topical agents.

• Wounds with signs of critical colonization or early local infection
• Wounds with biofilm suspected (stalled healing, recurrent exudate, tissue that looks "stuck")
• Inflammatory-phase wounds that are not progressing despite standard care
• As a primary wound contact layer to reduce microbial load before applying a secondary dressing

Silver Alginate Primary Dressings

For wounds with moderate to heavy exudate during the inflammatory phase, silver alginate dressings provide dual-action management: the alginate fiber absorbs wound fluid and forms a gel that maintains moisture balance, while ionic silver delivers a sustained antimicrobial barrier within the dressing.

• Wounds with signs of critical colonization or infection
• Moderate to heavily exudating wounds where moisture management is a priority
• Diabetic foot ulcers, pressure injuries, and venous leg ulcers in the inflammatory phase
• Post-surgical wounds in higher-risk patients with elevated infection risk

Stage 3: Proliferation — Build New Tissue, Support the Wound Bed

What Is Happening

Proliferation is where visible healing occurs. Fibroblasts migrate into the wound and begin synthesizing collagen — initially type III (weaker, provisional) and later type I (stronger, permanent). Granulation tissue — the pink, moist, granular tissue that fills the wound bed — is formed. Simultaneously, angiogenesis creates new blood vessels to supply the growing tissue, and epithelialization begins as keratinocytes migrate inward from the wound margins.

A healthy proliferating wound has a moist, beefy-red granulation bed, minimal exudate, and visible epithelial advancement at the edges. A wound that has granulation tissue but is not contracting or epithelializing may need additional support.

Product Considerations

The proliferative phase calls for products that support the wound matrix, maintain a moist healing environment, and provide structural scaffolding for new tissue formation.

Collagen Primary Dressings

Collagen dressings are among the most clinically relevant products for the proliferative phase. Collagen is the primary structural protein in the extracellular matrix, and exogenous collagen dressings provide a scaffold that supports fibroblast migration, promotes granulation tissue formation, and helps regulate the wound environment. They are particularly valuable in wounds where the healing process has stalled despite a clean, granulating bed.

• Wounds with granulating tissue that require support for continued progression
• Chronic non-healing wounds that have stalled in the inflammatory phase
• Diabetic foot ulcers and venous leg ulcers where tissue regeneration is a priority
• Post-surgical wounds requiring a biocompatible primary layer

Wound Allografts

For complex chronic wounds that have failed to progress with standard advanced dressings, placental membrane allografts represent a significant escalation in biological support. These grafts deliver a full-thickness placental membrane containing growth factors, cytokines, and extracellular matrix proteins that actively stimulate tissue regeneration rather than simply supporting it passively.

• Diabetic foot ulcers, venous leg ulcers, and pressure injuries that have not responded to standard advanced wound care
• Wounds with a clean granulating bed but minimal epithelial advancement over four or more weeks
• Post-surgical wounds with significant tissue loss requiring biologic scaffolding
• Wounds where the biological environment needs active regenerative support, not just protection

Stage 4: Remodeling — Protect the Maturing Wound

What Is Happening

Remodeling begins once the wound has closed and continues for months to years. Type III collagen is gradually replaced by the stronger type I collagen, fibers are reorganized along lines of tension, and the scar matures. The wound will ultimately achieve approximately 80% of the tensile strength of the original tissue — never quite returning to its pre-injury state.

During early remodeling, the newly closed wound remains fragile and vulnerable to breakdown. Patients with diabetes, vascular disease, or nutritional deficits are at particular risk for wound recurrence during this phase.

Product Considerations

The focus shifts from active wound management to protection, offloading, and prevention of recurrence. The wound no longer needs antimicrobial or regenerative products — it needs a stable, protected environment to complete maturation.

• Silicone secondary dressings to protect the fragile newly closed wound surface without trauma on removal
• Compression therapy for venous leg ulcers to prevent recurrence
• Offloading devices for diabetic foot wounds to reduce mechanical stress on the healed tissue
• Patient education on skin care, moisture management, and early signs of wound recurrence

Quick Reference: Stage-to-Product Matching

The table below summarizes the primary product recommendations by healing stage. Clinical judgment, wound assessment, and patient-specific factors should always guide final product selection.

The Bottom Line

Wound healing is a dynamic process, and the wound in front of you today is not the same wound it will be next week. Effective wound management requires ongoing reassessment — not just of the wound itself, but of which phase it is in and whether the current product selection is still appropriate.

At Nu Endeavors, we work alongside wound care centers, outpatient clinics, and surgical practices to ensure their teams have access to the right products at every stage of the healing continuum — from antimicrobial management in the inflammatory phase to advanced biologic support for wounds that need an extra push to close.

Product selection should always be guided by a qualified healthcare provider based on individual wound characteristics and clinical needs. This content is intended for informational and educational purposes only and does not constitute medical advice.